Duchenne muscular dystrophy – Basic Information

Go back

Duchenne muscular dystrophy is a serious genetic condition that causes muscles to gradually weaken and break down over time. It primarily affects boys and begins showing signs in early childhood, changing the way families live and plan for the future. Understanding this condition can help those affected access the care and support they need.

How Common Is Duchenne Muscular Dystrophy?

Duchenne muscular dystrophy, commonly known as DMD, affects approximately 1 in every 3,500 to 5,000 boys born worldwide. This makes it the most common type of muscular dystrophy (a group of diseases that cause muscle weakness and loss) and the most frequently inherited severe muscle disorder affecting children. The condition does not show a preference for any particular racial or ethnic group, meaning it can affect families from all backgrounds equally.[1][2]

While DMD primarily affects males, females can also be impacted in certain situations. About 2.5% to 20% of female carriers may experience some symptoms, though typically milder than those seen in males. In very rare cases, females can be severely affected. This pattern exists because of how the condition is inherited through families.[4]

When the organization Action Duchenne was founded in 2001, the average life expectancy for a young person living with DMD in the United Kingdom was in the late teens. Thanks to advances in care and management, life expectancy has now increased to the late twenties, with more people than ever living into their thirties and forties. This represents significant progress, though the condition remains serious and life-limiting.[6][20]

What Causes Duchenne Muscular Dystrophy?

DMD is caused by changes, called mutations, in a specific gene known as the DMD gene. This gene is located on the X chromosome and contains instructions for making a protein called dystrophin. Dystrophin acts like a shock absorber in muscle cells, helping to keep them strong and protecting them from damage when muscles contract and relax during movement.[2][3]

When someone has DMD, their body produces little to no dystrophin because the gene instructions are faulty. Without this protective protein, muscle fibers become fragile and vulnerable to injury every time they are used. Over time, muscle cells die after repeated cycles of damage, and the body cannot replace them. Instead, the empty spaces where healthy muscle used to be fill up with fat and scar tissue, which cannot perform the work of muscle. This is why muscles progressively weaken and lose their ability to function.[2][4]

⚠️ Important
Duchenne muscular dystrophy is not contagious and cannot be caught from another person. It is a genetic condition that is either inherited from parents or occurs as a spontaneous new mutation. There is currently no way to prevent DMD from occurring.

How DMD Is Inherited

DMD follows what scientists call an X-linked recessive pattern of inheritance. Understanding this requires knowing about chromosomes, which are packages of genetic information inside our cells. Humans have two sex chromosomes that determine biological sex: X and Y. Boys typically have one X chromosome (inherited from their mother) and one Y chromosome (from their father). Girls usually have two X chromosomes, one from each parent.[2]

Because the faulty gene is located on the X chromosome, boys are much more likely to have DMD. If a boy inherits an X chromosome with the DMD mutation, he will develop the condition because he has no second X chromosome to compensate. Girls, however, have a backup copy on their other X chromosome, which usually protects them from developing severe symptoms. These girls become carriers, meaning they carry the genetic change but typically do not show significant muscle weakness themselves.[2][4]

Female carriers can pass the altered gene to their children. Each son born to a carrier mother has a 50% chance of having DMD, and each daughter has a 50% chance of being a carrier herself. However, not all cases are inherited from carrier mothers. Approximately 30% of DMD cases occur due to spontaneous new mutations, meaning the genetic change happened for the first time in that child and was not passed down from a parent. This means any family can be affected by DMD, even without a family history.[4][10]

Who Is at Higher Risk?

The primary risk factor for developing DMD is being male, as the condition predominantly affects boys due to its X-linked inheritance pattern. Boys born to mothers who are known carriers of the DMD gene mutation have a significantly elevated risk, with a 50% chance of inheriting the condition. Families with a history of DMD or other forms of muscular dystrophy are also at higher risk for having affected children.[2][4]

However, it is important to understand that DMD can occur in any family, regardless of ethnic background or family history. The spontaneous mutations that cause about one-third of all DMD cases mean that even families with no previous history of muscle disease can have a child born with this condition. This unpredictability can be challenging for families who had no warning signs or family history to alert them to the possibility.[4]

Female carriers of the DMD mutation may also experience some health concerns themselves, though usually less severe than in males. Some carrier women develop heart problems as they age, even if they never experienced significant skeletal muscle weakness. This is why genetic counseling and family screening are recommended when DMD is diagnosed in a family member.[4]

Recognizing the Symptoms

The symptoms of DMD typically begin to appear in early childhood, usually between the ages of 2 and 4 years. However, some signs may be present even earlier, during infancy, though parents might not recognize them as concerning until the child gets older and developmental delays become more apparent. The primary symptom is muscle weakness, which starts gradually and worsens progressively over time.[1][2]

One of the earliest signs parents might notice is that their child is not reaching motor milestones at the expected ages. For example, a toddler with DMD might struggle to sit or stand independently, or may begin walking later than other children their age. Young children with DMD often have trouble keeping up with their peers during play. They may fall frequently, appear clumsy, or have difficulty running, jumping, or climbing stairs.[2][8]

Parents may observe that their child walks in an unusual way, often described as waddling. Children with DMD frequently walk on their toes rather than using their whole foot. When they fall down or sit on the floor, they have difficulty getting back up and may use their hands to “climb up” their own legs to reach a standing position. This characteristic movement, called the Gowers’ sign, happens because the hip and thigh muscles have become too weak to lift the body on their own.[2][10]

Another notable feature is that the calf muscles often appear larger than normal, a condition called pseudohypertrophy. This might seem contradictory since the disease causes muscle weakness, but the enlargement is not due to strong muscle. Instead, the calves enlarge because fat and scar tissue replace the dying muscle fibers, making the calves look bulky even though they are actually getting weaker.[2]

As DMD progresses through childhood, the pattern of muscle weakness spreads. The weakness initially affects muscles closest to the body’s center, called proximal muscles, such as those in the shoulders, upper arms, hips, and thighs. Later, the weakness extends to muscles farther from the center, called distal muscles, which are in the forearms, hands, lower legs, and feet.[1][21]

By the time children with DMD reach ages 9 to 13, most lose the ability to walk independently and require a wheelchair for mobility. This stage is called becoming non-ambulant. As the disease continues into the teenage years and beyond, upper body and arm muscles also weaken, making it harder to perform everyday tasks like eating, writing, or using electronic devices.[6]

Two of the most serious complications of DMD involve the heart and breathing muscles. As the condition progresses, the heart muscle weakens and becomes enlarged, a condition called cardiomyopathy. This occurs in almost all people with DMD, usually beginning around age 13 or sometimes earlier. The weakening of respiratory muscles makes breathing increasingly difficult. Many people with DMD eventually require assistance with breathing, either through devices that push air into the lungs or, in more advanced stages, a surgical opening in the throat called a tracheotomy to help air reach the lungs.[2][6]

Beyond physical symptoms, some children with DMD experience learning difficulties or delays in speech and language development. These cognitive challenges are not related to intelligence but occur because dystrophin is also present in certain parts of the brain, and its absence can affect how the brain processes information.[2]

Can Duchenne Muscular Dystrophy Be Prevented?

Unfortunately, there is currently no way to prevent Duchenne muscular dystrophy from occurring. Because DMD is caused by genetic mutations that are either inherited or occur spontaneously, the condition cannot be avoided through lifestyle changes, diet, supplements, or any other preventive measures. Families cannot alter whether a child will be born with DMD once conception has occurred with a mutation in the DMD gene.[2]

However, families with a known history of DMD or who have had a child with DMD can take steps to understand their risks for future pregnancies. Genetic counseling provides families with information about inheritance patterns, the likelihood of having another affected child, and options for family planning. Genetic testing can identify whether a woman is a carrier of the DMD mutation, which helps inform decisions about having children.[2]

For families at risk, prenatal testing during pregnancy can determine whether a developing baby has DMD. Tests such as amniocentesis or chorionic villus sampling allow doctors to examine the baby’s genetic material before birth. This information can help families prepare for the birth of a child with special medical needs or make informed decisions about the pregnancy.[2]

Another important development is newborn screening for DMD. Some regions have begun testing all newborn boys for elevated levels of an enzyme called creatine kinase, which leaks from damaged muscles in babies with DMD. Early identification through newborn screening allows for earlier diagnosis and earlier start of treatments and supportive care, which can improve outcomes and quality of life, even though the condition itself cannot be prevented.[5]

How the Body Changes in DMD

Understanding what happens inside the body in DMD helps explain why the symptoms occur and progress the way they do. The fundamental problem is the absence of dystrophin, the protein that normally provides structural support to muscle fibers. Dystrophin works like a shock absorber, connecting the interior of muscle cells to their outer membrane. This connection is crucial because muscles constantly stretch and contract, which creates mechanical stress.[2][5]

When dystrophin is missing, muscle cell membranes become fragile and tear easily during normal muscle use. Each time a muscle contracts, without dystrophin to protect them, tiny tears occur in the cell membrane. These tears allow substances that should stay outside the cell to leak in, and important proteins inside the cell to leak out. This damage triggers an inflammatory response, as the body tries to repair the injury.[4][5]

At first, the body attempts to repair damaged muscle fibers, and young children may even appear to have stronger muscles temporarily as the body works to compensate. However, repeated cycles of damage and attempted repair eventually overwhelm the muscle’s regenerative capacity. Muscle cells die, and the body cannot produce new muscle cells fast enough to replace them. Instead, the spaces left by dead muscle cells fill with connective tissue, fat, and scar tissue. This explains the paradox of enlarged calf muscles that are actually weak rather than strong.[2][4]

The progressive replacement of functional muscle with non-functional tissue explains the relentless progression of weakness in DMD. As more muscle is lost, children lose abilities they once had. The condition affects not only skeletal muscles used for movement but also smooth muscles in internal organs and cardiac muscle in the heart. Dystrophin’s absence in the heart causes similar damage to heart muscle cells, leading to cardiomyopathy over time.[5]

Another important factor in DMD progression is inflammation. The constant muscle damage triggers ongoing inflammation throughout the body. This chronic inflammation contributes to more muscle destruction beyond the initial mechanical damage from missing dystrophin. Controlling this inflammatory response is one reason why certain medications, particularly corticosteroids, are used in DMD treatment.[5]

As skeletal muscles weaken, secondary complications develop. Muscle weakness leads to joint stiffness and reduced range of motion because muscles and tendons shorten, a process called contractures. Weakness of back muscles causes the spine to curve abnormally to the side, called scoliosis, which is common in DMD and can affect sitting posture, comfort, and even breathing. Reduced mobility also leads to bone density loss, making bones more fragile and prone to fractures.[6]

The breathing difficulties that develop in DMD occur because the diaphragm and other respiratory muscles weaken. The diaphragm is the main muscle used for breathing, and when it cannot work properly, the lungs cannot expand fully. This makes it harder to take deep breaths and to cough effectively to clear mucus from the airways. Weakened cough makes people with DMD more vulnerable to lung infections, which can become serious.[2]

Understanding these bodily changes helps healthcare providers and families anticipate needs and complications before they become severe. It also guides the development of new therapies aimed at different aspects of the disease process, from replacing missing dystrophin to reducing inflammation and supporting muscle regeneration.[5]

⚠️ Important
The progression of DMD varies from person to person. While the general pattern is predictable, some individuals may progress more slowly or quickly than others. Regular medical monitoring helps track disease progression and adjust care plans to meet changing needs as the condition advances.

Ongoing Clinical Trials on Duchenne muscular dystrophy

  • Study of SAT-3247 Compared to Placebo for Patients with Duchenne Muscular Dystrophy Who Can Walk

    Recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Belgium Poland Spain
  • Study of ENTR-601-45 Safety and Effectiveness in Patients with Duchenne Muscular Dystrophy Who Can Skip Exon 45

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Italy The Netherlands Spain
  • Study of ENTR-601-44 in Children with Duchenne Muscular Dystrophy Who Are Eligible for Exon 44 Skipping Treatment

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Italy Spain
  • Study of SGT-003 Gene Therapy for Safety and Tolerability in Walking Males with Duchenne Muscular Dystrophy

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Long-Term Safety and Efficacy Study of Givinostat for Patients with Duchenne Muscular Dystrophy Previously Treated with Givinostat

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Spain
  • Study on the Safety and Effects of Givinostat in Young Children with Duchenne Muscular Dystrophy (Ages 2 to Less Than 6 Years)

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Italy The Netherlands
  • Long-term Safety Study of Delandistrogene Moxeparvovec for Patients with Duchenne Muscular Dystrophy Who Previously Received SRP-9001

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Germany Italy Spain
  • Efficacy and Safety of Givinostat for Non-Ambulant Patients with Duchenne Muscular Dystrophy

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia France Germany Italy The Netherlands +3
  • Study on the Safety and Effects of SQY51 for Children and Adults with Duchenne Muscular Dystrophy

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of Microdystrophin (GNT0004) Gene Therapy for Duchenne Muscular Dystrophy in Boys Who Can Walk

    Recruiting

    2 1 1
    Investigated diseases:
    Belgium France Spain

References

https://www.mda.org/disease/duchenne-muscular-dystrophy

https://my.clevelandclinic.org/health/diseases/23538-duchenne-muscular-dystrophy-dmd

https://www.parentprojectmd.org/about-duchenne/what-is-duchenne/

https://www.ncbi.nlm.nih.gov/books/NBK482346/

https://www.nature.com/articles/s41572-021-00248-3

https://www.duchenne.org.uk/duchenne-facts/

https://www.akronchildrens.org/kidshealth/en/parents/duchenne-md.html

https://www.healthdirect.gov.au/duchenne-muscular-dystrophy

https://www.mda.org/disease/duchenne-muscular-dystrophy/medical-management

https://my.clevelandclinic.org/health/diseases/23538-duchenne-muscular-dystrophy-dmd

https://pubmed.ncbi.nlm.nih.gov/36963652/

https://www.ema.europa.eu/en/news/new-treatment-against-duchenne-muscular-dystrophy

https://www.parentprojectmd.org/care/approved-therapies-for-duchenne-muscular-dystrophy/

https://www.ncbi.nlm.nih.gov/books/NBK482346/

https://duchenneandyou.com/living-with-duchenne/

https://www.parentprojectmd.org/care/for-healthcare-providers/caring-for-duchenne/

https://www.healthline.com/health/adult-care-duchenne-muscular-dystrophy

https://www.parentprojectmd.org/care/care-guidelines/by-stage/late-non-ambulatory/

https://musculardystrophynews.com/duchenne-muscular-dystrophy-caregiver-tips/

https://www.actionduchenne.org/what-is-duchenne/supporting-you/guides-and-information/adults-living-with-duchenne-muscular-dystrophy/

https://www.mda.org/disease/duchenne-muscular-dystrophy

FAQ

At what age are children typically diagnosed with Duchenne muscular dystrophy?

Diagnosis usually occurs between ages 2 and 5 years, when symptoms become noticeable enough for parents or doctors to recognize developmental delays or muscle weakness. However, some children may be diagnosed earlier through newborn screening programs, while others may not receive a diagnosis until later in childhood.

Can girls get Duchenne muscular dystrophy or is it only boys?

DMD primarily affects boys due to its X-linked inheritance pattern. However, girls can be affected in rare circumstances, and about 2.5% to 20% of female carriers may experience some symptoms. Female carriers may also develop heart problems later in life even without significant muscle weakness.

What is the life expectancy for someone with Duchenne muscular dystrophy?

Life expectancy has improved significantly with better care and currently averages in the late twenties. Very few people with DMD lived beyond age 30 in the past, but advances in respiratory care, heart management, and other treatments have led to more individuals living into their thirties and forties.

How is Duchenne muscular dystrophy diagnosed?

Diagnosis typically involves blood tests to check for elevated creatine kinase enzyme levels, followed by genetic testing of the DMD gene to confirm the diagnosis. Sometimes a muscle biopsy is performed to look for abnormal levels of dystrophin protein. Genetic testing is considered the best way to definitively diagnose DMD.

When do children with DMD typically lose the ability to walk?

Most children with DMD lose the ability to walk independently between ages 9 and 13 and require a wheelchair for mobility. The exact timing varies from person to person, and treatments like corticosteroids can help prolong walking ability for some time.

🎯 Key takeaways

  • DMD affects approximately 1 in 3,500 to 5,000 boys born worldwide, making it the most common severe inherited muscle disorder in children
  • The condition is caused by mutations in the DMD gene that prevent production of dystrophin, a protein that protects muscles from damage during movement
  • About 30% of DMD cases occur as spontaneous new mutations, meaning any family can be affected regardless of family history
  • Early signs include developmental delays, frequent falls, toe walking, difficulty climbing stairs, and using hands to push up from the ground
  • The disease progressively affects not only skeletal muscles but also heart and breathing muscles, leading to serious complications
  • Life expectancy has improved from late teens to late twenties on average, with increasing numbers of individuals living into their thirties and forties
  • While there is no cure or way to prevent DMD, newborn screening and early diagnosis can help families access earlier treatment and supportive care
  • Female carriers may experience mild symptoms and can develop heart problems as they age, making family screening and genetic counseling important